Impact of early disease factors on metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort

Research output: Contribution to journalArticlepeer-review


  • Ben Parker
  • Murray B Urowitz
  • Dafna D Gladman
  • Mark Lunt
  • Rachelle Donn
  • Sang-Cheol Bae
  • Jorge Sanchez-Guerrero
  • Juanita Romero-Diaz
  • Daniel J Wallace
  • Ann E Clarke
  • Sasha Bernatsky
  • Ellen M Ginzler
  • David A Isenberg
  • Anisur Rahman
  • Joan T Merrill
  • Graciela S Alarcón
  • Barri J Fessler
  • Paul R Fortin
  • John G Hanly
  • Michelle Petri
  • Kristjan Steinsson
  • Mary Anne Dooley
  • Susan Manzi
  • Munther A Khamashta
  • Rosalind Ramsey-Goldman
  • Asad A Zoma
  • Gunnar K Sturfelt
  • Ola Nived
  • Cynthia Aranow
  • Meggan Mackay
  • Manuel Ramos-Casals
  • Ronald F van Vollenhoven
  • Kenneth C Kalunian
  • Guillermo Ruiz-Irastorza
  • S Sam Lim
  • Diane L Kamen
  • Christine A Peschken
  • Murat Inanc
  • Ian N Bruce

Colleges, School and Institutes

External organisations

  • University of Manchester


The metabolic syndrome (MetS) may contribute to the increased cardiovascular risk in systemic lupus erythematosus (SLE). We examined the association between MetS and disease activity, disease phenotype and corticosteroid exposure over time in patients with SLE.


Original languageEnglish
JournalAnnals of the Rheumatic Diseases
Publication statusPublished - 1 Apr 2014